NCT00968591View on ClinicalTrials.gov

Pharmacokinetics of Everolimus in Subjects With Hepatic Insufficiency

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

November 30, 2010

Conditions
Hepatic Insufficiency
Interventions
DRUG

Everolimus

Trial Locations (3)

Unknown

Novartis Investigative Site, Frankfurt

Novartis Investigative Site, Moscow

Novartis Investigative Site, Singapore

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY